Investing.com1月
Citiが肺気腫治療デバイス企業Pulmonxを「中立」に格下げ、成長の ...
水曜日、CitiはPulmonx Corp. (NASDAQ:LUNG)の格付けを「買い」から「中立」に引き下げ、同時に目標株価を従来の17.00ドルから大幅に引き下げて7.50ドルとしました。 この再評価は、同社が一貫してガイダンスを達成し、年初来の株価パフォーマンスが約50%下落して ...
Investing.com1月
Pulmonx社の最高商業責任者、約27,063ドル相当の株式を売却
同社の株式はNASDAQでLUNGのティッカーシンボルで取引されています。 他の最近のニュースでは、Pulmonx Corporationは力強い第3四半期の業績を報告し、世界全体の売上高が前年比15%増の2040万ドルに達したことが強調されました。米国市場が重要な役割を果たし ...
Yahoo Finance23 日
Pulmonx Corporation (LUNG)
REDWOOD CITY, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced ...
Brokerages Set Pulmonx Co. (NASDAQ:LUNG) Price Target at $12.75
Shares of Pulmonx Co. (NASDAQ:LUNG – Get Free Report) have been assigned an average rating of “Moderate Buy” from the six ...
MSN による配信1月
Does Pulmonx (LUNG) Have the Potential to Rally 117.74% as Wall Street Analysts Expect?
Pulmonx Corporation (LUNG) closed the last trading session at $6.20, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by ...
TipRanks on MSN2月
Pulmonx Corporation’s Financial Stability at Risk Amid Product and Market Challenges
Pulmonx Corporation (LUNG) has disclosed a new risk, in the Share Price & Shareholder Rights category. Pulmonx Corporation ...
Business Wire2月
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, and the American Lung ...
Stockhouse1月
Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for ...
Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, and the American Lung Association are continuing their ...